Maxifed is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Mcr American Pharmaceuticals, Inc.. The primary component is Guaifenesin; Pseudoephedrine Hydrochloride.
| Product ID | 58605-101_f954e296-1429-4985-9d04-a20b67e2cf71 |
| NDC | 58605-101 |
| Product Type | Human Otc Drug |
| Proprietary Name | Maxifed |
| Generic Name | Guaifenesin And Pseudoephedrine Hydrochloride |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-04-01 |
| Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Labeler Name | MCR American Pharmaceuticals, Inc. |
| Substance Name | GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Active Ingredient Strength | 360 mg/1; mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2018-04-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph final |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2018-04-01 |
| Marketing Category | OTC monograph final |
| Application Number | part341 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-04-01 |
| Ingredient | Strength |
|---|---|
| GUAIFENESIN | 360 mg/1 |
| SPL SET ID: | 8a1be614-2a78-4899-9697-774479f2daa5 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 58605-101 | Maxifed | GUAIFENESIN and Pseudoephedrine Hydrochloride |
| 66992-281 | Entex T | Guaifenesin and Pseudoephedrine Hydrochloride |
| 79903-125 | equate mucus d | guaifenesin and pseudoephedrine hydrochloride |
| 0363-0077 | Guaifenesin and Pseudoephedrine Hydrochloride | Guaifenesin and Pseudoephedrine Hydrochloride |
| 41415-994 | Guaifenesin and Pseudoephedrine Hydrochloride | Guaifenesin and Pseudoephedrine Hydrochloride |
| 51660-071 | Guaifenesin and Pseudoephedrine Hydrochloride | Guaifenesin and Pseudoephedrine Hydrochloride |
| 62011-0475 | Guaifenesin and Pseudoephedrine Hydrochloride | Guaifenesin and Pseudoephedrine Hydrochloride |
| 0363-9930 | Guaifenesin D | Guaifenesin and Pseudoephedrine Hydrochloride |
| 0536-1333 | Guaifenesin D | Guaifenesin and Pseudoephedrine Hydrochloride |
| 51316-993 | Guaifenesin D | Guaifenesin and Pseudoephedrine Hydrochloride |
| 70000-0580 | Guaifenesin D | Guaifenesin and Pseudoephedrine Hydrochloride |
| 51316-970 | MAXIMUM STRENGTH Mucus D | guaifenesin and pseudoephedrine hydrochloride |
| 50090-1075 | Mucinex D | Guaifenesin and Pseudoephedrine Hydrochloride |
| 50090-1076 | Mucinex D | Guaifenesin and Pseudoephedrine Hydrochloride |
| 63824-041 | Mucinex D | Guaifenesin and Pseudoephedrine Hydrochloride |
| 63824-057 | Mucinex D | Guaifenesin and Pseudoephedrine Hydrochloride |
| 68258-3035 | Mucinex D | Guaifenesin and Pseudoephedrine Hydrochloride |
| 70518-0523 | Mucinex D | Guaifenesin and Pseudoephedrine Hydrochloride |
| 0536-1137 | Mucus Relief D | Guaifenesin and Pseudoephedrine Hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() MAXIFED 75130397 2242345 Live/Registered |
MCR American Pharmaceuticals, Inc. 1996-07-05 |
![]() MAXIFED 74546782 not registered Dead/Abandoned |
JOHNSON & JOHNSON 1994-07-07 |
![]() MAXIFED 74026406 not registered Dead/Abandoned |
Johnson & Johnson 1990-02-06 |